ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: CT Scanning Of The Brain Subject Of Consensus Development Conference; CCI Plans Congress Events

July 10, 1981

Cranial Radiation Eliminated With Personalized Chemo

August 28, 2009

ACS Endorses Clinton Health Care Reform, Wit qualifications

March 11, 1994

Nucynta ER Approved For Managing Chronic Pain In Adults

September 30, 2011

GM Foundation Awards Prizes

June 13, 2003

Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal.

August 13, 2004